| 原料品名 | ATRACURIUM BESYLATE |
|---|---|
| 原料中文名称 | 苯磺阿曲库铵 |
| 英文别名 | 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium dibenzenesulfonate; 2,2'-[1,5-PENTANEDIYLBIS[OXY(3-OXO-3,1-PROPANEDIYL)]]BIS[1-[3,4-DIMETHOXYPHENYL)METHYL]-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYLISOQUINOLINIUM]DIBENZENESULFONATE; ATRACURIUM BESILATE; BW-33A; TRACRIUM; Atracurim besylate Bp; ATRACURIUM BESILATE INJECTION; AtracuriumBesylate(DMF); CisatracuriumBesilete; AttracuriumBesylate; CIS-ATRACURIUM BESYLETE 2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium Benzenesulfonate; Atracurium Dibesylate; Tracur; Wellcome 33A74; ATRACURIUM BESYLAT; 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolinium]dibenzenesulfonate; Atracuricum Besilate; ATRACURIUM BESYLATE EP/BP |
| 中文别名 | 苯磺阿曲库胺,神经肌肉阻断剂;阿曲库铵苯磺酸;2,2'-[1,5-戊二基双[氧(3-氧-3,1-丙二基)]]双[1-[(3,4-二甲氧基苯基)甲基]-1,2,3,4-四氢-6,7-二甲氧基-2-甲基异喹啉铵]二苯磺酸盐;苯磺酸阿曲库铵,安托肌松;苯磺安托肌松;阿曲库胺苯磺酸盐 (异构体混合物);安托肌松,苯磺阿曲库铵;2,1-丙二基)]]双[1-(3,7-二甲氧基-2-甲基异喹啉]二苯磺酸盐 |
| 化学名称 | benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate |
| 分子式 | C65H82N2O18S2 |
| 分子量 | 1243.48 |
| CAS号 | 64228-81-5 |
| EINECS编号 | 暂无权限 |
| 结构式图片 | 暂无权限 |
| 美国DMF登记 | 暂无权限 |
供应商信息
| 企业名称 | Teva Pharmaceutical Industries Ltd |
|---|---|
| 企业类型 | 生产商 |
| 国家/地区 | 以色列 |
| 公司官网 | 暂无权限 |
| 公司简介 | We are proud that since Teva’s establishment in 1901, healthcare providers together with patients and caregivers have been using our accessible generic and innovative products. Today, our portfolio of around 3,500 products is among the largest of any pharmaceutical company in the world. Nearly 200 million people in 60 countries benefit from one of Teva's quality medicines every day. We invest in research and development of generic medicines and biopharmaceuticals, carrying on the legacy of more than a century of finding new ways to help patients improve their lives. This defines our values as a company and characterizes how we do business and approach medicine. |
| 备注 | 若未能联系上供应商，可在药智通发布求购信息（https://s.yaozh.com/Purchase/release），或联系药智通客服17318480790（微信同号） |
扩展信息
